1Ferko B, Stasakova J, Romanova J, et al. Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. J Virol, 2004, 78:13037-13045.
2Nemeroff ME, Barabino SM, Li Y, et al. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3' end formation of cellular pre-mRNAs. Mol Cell, 1998, 1:991-1000.
3Chen Z, Li Y, Krug RM. Influenza A virus NS1 protein targets poly(A) -binding protein II of the cellular 3' - end processing machinery. EMBO J, 1999,18:2273-2283.
4Donelan NR, Dauber B, Wang X, et al. The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation. J Virol, 2004,78 : 11574-11582.
5Burgui I, Aragon T, Ortin J, et al. PABP1 and elF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes. J Gen Virol, 2003, 84: 3263-3274.
6Li Z, Jiang Y, Jiao P, et al. TheNS1 gene contributes to the virulence of H5N1 avian influenza viruses. J Virol, 2006, 80: 11115-11123.
7Ivanova VT, Matiushina RO, Slepushkin AN, et al. Epidemic strains influenza viruses A and B in the 2005-2006 seasons in Russia. Vopr Virusol, 2008,53 : 13-18.
8Thompson JD, Gibson TJ, Plewniak F, et al. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools, Nucleic Acids Res, 1997,25 : 4876-4882.
9Tamura K, Dudley J, Nei M, et al. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol, 2007, 24: 1596-1599.
10Yang Z, Ro S, Rannala B. Likelihood models of somatic mutation and codon substitution in cancer genes. Genetics, 2003, 165 : 695-705.
